World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

World Top Biopharmaceutical Companies 2024
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.

  1. Inhibrx Inc.

    World Rank (Jan-05-2024)
    6,046
    Market Cap (Jan-05-2024)
    1.809 Billion USD
    World Rank (Jul-30-2023)
    7,998
    World Rank (Dec-25-2022)
    7,998
    Market Cap (Dec-25-2022)
    1.081 Billion USD
    World Rank (Jan-07-2022)
    8,138
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    7,125 Million USD
    Annual Net Income in USD
    -81 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Inhibrx is a Clinical Stage Biotechnology company developed a diverse pipeline of therapeutic candidates specifically designed to leverage the power of core sdAb (single-domain antibody) platform and protein engineering expertise. The company annual revenue is 34.1 million USD and 80 employees as on 2020. The headquarters is in USA.
    Company Website
    INHIBRX, INC.

  2. AbCellera Biologics Inc.

    World Rank (Jan-05-2024)
    6,216
    Market Cap (Jan-05-2024)
    1.724 Billion USD
    World Rank (Jul-30-2023)
    5,362
    Market Cap (Jul-30-2023)
    2.220 Billion USD
    World Rank (Dec-25-2022)
    4,125
    Market Cap (Dec-25-2022)
    2.955 Billion USD
    World Rank (Jan-07-2022)
    4,491
    Market Cap (Jan-07-2022)
    3.33 Billion USD
    Annual Revenue in USD
    288 Million USD
    Annual Net Income in USD
    118 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Canada
    Company Profile
    ABCELLERA BIOLOGICS INC. is Biotechnology sector company with headquarters is in Vancouver, Canada.
    Company Website
    ABCELLERA BIOLOGICS INC.
    Wikipedia
    Wikipedia

  3. Vericel Corporation

    World Rank (Jan-05-2024)
    6,459
    Market Cap (Jan-05-2024)
    1.623 Billion USD
    World Rank (Jul-30-2023)
    6,143
    Market Cap (Jul-30-2023)
    1.797 Billion USD
    World Rank (Dec-25-2022)
    7,816
    Market Cap (Dec-25-2022)
    1.125 Billion USD
    World Rank (Jan-07-2022)
    6,909
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    164 Million USD
    Annual Operating Income in USD
    -17 Million USD
    Annual Net Income in USD
    -17 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bio pharmaceutical company with headquarters is in USA.
    Company Website
    VERICEL

  4. Global Blood Therapeutics

    World Rank (Jan-05-2024)
    6,607
    World Rank (Jul-30-2023)
    6,607
    World Rank (Dec-25-2022)
    6,607
    World Rank (Jan-07-2022)
    6,607
    Market Cap (Jan-07-2022)
    1.85 Billion USD
    Annual Revenue in USD
    194 Million USD
    Annual Net Income in USD
    -303 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile

    Global Blood Therapeutics is a Biopharmaceutical Company. It is to transform the treatment of sickle cell disease and an overlooked rare condition and help address the urgent needs of the community. The company medicine is the first treatment approved by the FDA to target an underlying cause of SCD. The headquarters is in USA.

    Company Website
    GLOBAL BLOOD THERAPEUTICS INC

  5. Cansino Biologics

    World Rank (Jan-05-2024)
    6,715
    Market Cap (Jan-05-2024)
    1.516 Billion USD
    World Rank (Jul-30-2023)
    5,684
    Market Cap (Jul-30-2023)
    2.030 Billion USD
    World Rank (Dec-25-2022)
    3,500
    Market Cap (Dec-25-2022)
    3.702 Billion USD
    World Rank (Jan-07-2022)
    2,240
    Market Cap (Jan-07-2022)
    8.02 Billion USD
    Annual Revenue in USD
    675 Million USD
    Annual Net Income in USD
    300 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ HongKong
    Company Profile
    CanSino Biologics is an Innovative Biopharmaceutical company. It is currently developing 16 vaccine candidates for 13 infectious disease areas, preventing meningitis, pneumonia, tuberculosis, COVID-19, Ebola virus disease, pertussis, diphtheria, tetanus, shingles etc. The headquarters is in China.
    Company Website
    CANSINO BIOLOGICS

  6. Constellation Pharmaceuticals

    World Rank (Jan-05-2024)
    6,721
    World Rank (Jul-30-2023)
    6,721
    World Rank (Dec-25-2022)
    6,721
    World Rank (Jan-07-2022)
    6,721
    Annual Revenue in USD
    8,614 Million USD
    Annual Net Income in USD
    1,998 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Company Profile
    Constellation Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company using expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression.
    Company Website
    CONSTELLATION PHARMACEUTICALS

  7. Kymera Therapeutics Inc.

    World Rank (Jan-05-2024)
    6,735
    Market Cap (Jan-05-2024)
    1.510 Billion USD
    World Rank (Jul-30-2023)
    7,820
    Market Cap (Jul-30-2023)
    1.208 Billion USD
    World Rank (Dec-25-2022)
    6,679
    Market Cap (Dec-25-2022)
    1.453 Billion USD
    World Rank (Jan-07-2022)
    5,018
    Market Cap (Jan-07-2022)
    2.86 Billion USD
    Annual Revenue in USD
    47 Million USD
    Annual Operating Income in USD
    -154 Million USD
    Annual Net Income in USD
    -154 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kymera is a Biopharmaceutical company. It is a developing novel protein degrader therapeutics to treat disease in powerful new ways which harness the body's natural protein degradation system to selectively degrade disease causing proteins with the goal of completely removing them from the body. The company annual revenue is 10.4 million USD and 67 employees as on 2019. The headquarters is in USA.
    Company Website
    KYMERA THERAPEUTICS, INC.

  8. Arcus Biosciences

    World Rank (Jan-05-2024)
    6,836
    Market Cap (Jan-05-2024)
    1.477 Billion USD
    World Rank (Jul-30-2023)
    7,002
    Market Cap (Jul-30-2023)
    1.455 Billion USD
    World Rank (Dec-25-2022)
    6,609
    Market Cap (Dec-25-2022)
    1.478 Billion USD
    World Rank (Jan-07-2022)
    5,322
    Market Cap (Jan-07-2022)
    2.63 Billion USD
    Annual Revenue in USD
    112 Million USD
    Annual Operating Income in USD
    -280 Million USD
    Annual Net Income in USD
    -267 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile
    Arcus is a Biopharmaceutical company aiming to bring together scientists, physicians and advisors to focus on developing best in class cancer therapies. The company annual revenue is 77.8 million USD and 108 employees as on 2019. The headquarters is in USA.
    Company Website
    ARCUS BIOSCIENCES

  9. Disc Medicine Inc.

    World Rank (Jan-05-2024)
    6,852
    Market Cap (Jan-05-2024)
    1.472 Billion USD
    World Rank (Jul-30-2023)
    8,317
    Market Cap (Jul-30-2023)
    1.089 Billion USD
    Headquarters Country
    USA
    Company Website
    DISC MEDICINE INC.

  10. Keros Therapeutics Inc.

    World Rank (Jan-05-2024)
    6,873
    Market Cap (Jan-05-2024)
    1.464 Billion USD
    World Rank (Jul-30-2023)
    7,679
    Market Cap (Jul-30-2023)
    1.242 Billion USD
    World Rank (Dec-25-2022)
    7,230
    Market Cap (Dec-25-2022)
    1.286 Billion USD
    World Rank (Jan-07-2022)
    8,347
    Market Cap (Jan-07-2022)
    1.24 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -107 Million USD
    Annual Net Income in USD
    -104 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Keros Therapeutics is a Clinical Stage Biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics by leveraging deep understanding of specifically hematopoiesis and musculoskeletal systems. The company annual revenue is 10 million USD and 23 employees as on 2019. The headquarters is in USA.
    Company Website
    KEROS THERAPEUTICS, INC.

Share